What's new

PSUSA/00010483/202406

PSUSA/00010483/202406

Mar 6, 2025 - 13:48
 0
PSUSA/00010483/202406
PSUSA/00010483/202406
Read More

Tags:

Previous Article

Harmony Gold well down the track with its cost-effective renewable-energy build

Next Article

Human medicines European public assessment report (EPAR): Tygacil, tigecycline, ...

Related Posts

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Orphan designation: Clofutriben Treatment of Cushing's syndrome of endogenous origin, 16/01/2025 Positive

Orphan designation: Clofutriben Treatment of Cushing&#0...

Feb 20, 2025  0

EMA human resources strategy: Priorities 2023-2025

Feb 9, 2025  0